Brown Advisory
ALXN

Brown Advisory’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,403
Closed -$626K 1157
2021
Q2
$626K Sell
3,403
-53
-2% -$9.75K ﹤0.01% 802
2021
Q1
$528K Buy
3,456
+740
+27% +$113K ﹤0.01% 830
2020
Q4
$424K Buy
2,716
+377
+16% +$58.9K ﹤0.01% 811
2020
Q3
$268K Sell
2,339
-2,609
-53% -$299K ﹤0.01% 839
2020
Q2
$555K Buy
4,948
+1,218
+33% +$137K ﹤0.01% 707
2020
Q1
$336K Buy
3,730
+1,559
+72% +$140K ﹤0.01% 762
2019
Q4
$236K Sell
2,171
-56
-3% -$6.09K ﹤0.01% 942
2019
Q3
$218K Sell
2,227
-51
-2% -$4.99K ﹤0.01% 932
2019
Q2
$298K Sell
2,278
-15,833
-87% -$2.07M ﹤0.01% 872
2019
Q1
$2.45M Buy
18,111
+4,418
+32% +$597K 0.01% 588
2018
Q4
$1.33M Sell
13,693
-10,106
-42% -$984K ﹤0.01% 691
2018
Q3
$3.31M Buy
23,799
+3,538
+17% +$492K 0.01% 538
2018
Q2
$2.52M Buy
20,261
+15,169
+298% +$1.88M 0.01% 578
2018
Q1
$567K Buy
5,092
+259
+5% +$28.8K ﹤0.01% 800
2017
Q4
$577K Sell
4,833
-2,007
-29% -$240K ﹤0.01% 837
2017
Q3
$960K Sell
6,840
-7,562
-53% -$1.06M ﹤0.01% 672
2017
Q2
$1.75M Sell
14,402
-2,494,322
-99% -$303M 0.01% 558
2017
Q1
$304M Sell
2,508,724
-727,210
-22% -$88.2M 1.04% 30
2016
Q4
$396M Sell
3,235,934
-636,832
-16% -$77.9M 1.41% 16
2016
Q3
$475M Buy
3,872,766
+825,135
+27% +$101M 1.63% 14
2016
Q2
$356M Buy
3,047,631
+581,703
+24% +$67.9M 1.25% 23
2016
Q1
$343M Buy
2,465,928
+232,397
+10% +$32.4M 1.19% 29
2015
Q4
$426M Buy
2,233,531
+335,663
+18% +$64M 1.45% 23
2015
Q3
$297M Buy
1,897,868
+383,966
+25% +$60.1M 1.06% 28
2015
Q2
$274M Buy
1,513,902
+1,460,505
+2,735% +$264M 0.89% 32
2015
Q1
$9.25M Buy
+53,397
New +$9.25M 0.03% 287